| 查看: 1621 | 回复: 4 | |||
[交流]
美国南密西西比大学 白逢伟教授课题组诚招病毒感染免疫方向的优秀硕博士(免学费)
|
|
Dr. Fengwei Bai’s laboratory in the Department of Biological Sciences at The University of Southern Mississippi (Hattiesburg, MS, USA) is look for a self-motived and hardworking Ph.D candidate to study the pathogensis of Zika virus, West Nile virus and dengue virus in mouse models, and to develop vaccines and anti-viral reagents. The Ph.D position will start from the fall semester 2018. Dr. Bai’s research is supported by grants from the NIH, American Heart Association and other funding agencies. The laboratory currently has three graduate students (two Ph.D and one master student). The lab research environment is very friendly, collaborative and productive. In last five years, Dr. Bai and his students published over 20 research articles in Journal of Immunology, Journal of Virology, Journal of Biological chemistry, Scientific Reports and etc.. Two recently graduated Ph.D students were recruited as postdoctoral fellows by the US National Aeronautics and Space Administration (NASA) and University of Chicago, respectively. The benefits of graduate students in the Department of Biological Sciences include tuition waiver, RA or TA support, and free health insurance. The basic qualification of a candidate must have a BS or a master degree in biology, medicine or other related fields with strong interests in study of Virology, Immunology and infectious diseases. For detail information regarding Dr. Bai’s research, please visit: https://www.usm.edu/biological-sciences/faculty/fengwei-bai Information regarding The University of Southern Mississippi: https://home.usm.edu Information regarding the city Hattiesburg: https://www.hattiesburgms.com Interested candidates please contact Dr. Fengwei Bai: Fengwei.bai@usm.edu |
» 猜你喜欢
一志愿华中农业071010,320求调剂
已经有5人回复
药学求调剂
已经有13人回复
求调剂推荐
已经有4人回复
290调剂生物0860
已经有40人回复
085400电子信息类(川大控制工程)求调剂可跨专业 求老师联系
已经有6人回复
材料工程281还有调剂机会吗
已经有42人回复
273求调剂
已经有6人回复
药学305求调剂
已经有6人回复
求调剂学校
已经有12人回复
山东省基金2026
已经有8人回复
2楼2017-11-04 02:51:50
3楼2017-11-04 19:57:34

4楼2017-11-06 17:14:34
5楼2017-11-09 03:32:27














回复此楼